|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prevalence of Nonresponsiveness to Aspirin in Patients with Symptomatic Peripheral Arterial Disease Using True Point of Care Testing显示文摘 | Dimitrios Karnabatidis Stavros Spiliopoulos Georgios Pastromas Panagiotis Kitrou Nikolaos Christeas Konstantinos Katsanos Dimitrios Siablis | 2014 | CardioVascular and Interventional Radiology2014，，： | 1 |
| 2 | Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease:the IDEAS randomized controlled trial显示文摘 | Siablis D Kitrou PM Spiliopoulos S | 2014 | JACC Cardiovasclnterv2014，7，9： | 1 |
| 3 | Clopidogrel Responsiveness in Patients Undergoing Peripheral Angioplasty显示文摘 | Georgios Pastromas Stavros Spiliopoulos Konstantinos Katsanos Athanasios Diamantopoulos Panagiotis Kitrou Dimitrios Karnabatidis Dimitrios Siablis | 2013 | CardioVascular and Interventional Radiology2013，，： | 1 |
| 4 | Platelet REsponsiveness to CLOpidogrel treatment after Peripheral endovascular procedures - The PRECLOP study: Clinical Impact and Optimal Cut-off Value of High On Treatment Platelet Reactivity显示文摘 | Stavros Spiliopoulos Georgios Pastromas Konstantinos Katsanos Panagiotis Kitrou Dimitrios Karnabatidis Dimitrios Siablis | 2013 | Journal of the American College of Cardiology2013，，： | 1 |
| 5 | Initial Experience With Ticagrelor in Patients With Critical Limb Ischemia and High On-Clopidogrel Platelet Reactivity Undergoing Complex Peripheral Endovascular Procedures显示文摘 | Stavros Spiliopoulos Konstantinos Katsanos Georgios Pastromas Athanasios Diamantopoulos Panagiotis Kitrou Dimitris Siablis Dimitris Karnabatidis | 2014 | CardioVascular and Interventional Radiology2014，，： | 1 |
| 6 | Paclitaxel- coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease the IDEAS randomized controlled trial显示文摘 | Siablis D Kitrou PM Spiliopoulos S | 2014 | JACC Cardiovasc Interv2014，7，： | 1 |
| 7 | Evaluation of zotarolimus eluting metal stent in animal ureters显示文摘 | Kallidonis P Kitrou P Karnabatidis D | 2011 | J Endourol2011，25，10： | 1 |
| 8 | Paclitaxel-coated balloon angioplasty versus drug-elutingstenting for the treatment of infrapopliteal long-segmentarterial occlusive disease: the IDEAS randomizedcontrolled trial显示文摘 | Siablis D Kitrou PM Spiliopoulos S | 2014 | JACC Cardiovasc Interv2014，7，9： | 1 |
| 9 | Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial显示文摘 | Kitrou PM Spiliopoulos S Katsanos K | 2015 | J Vasc Interv Radiol2015，26，3： | 1 |
| 10 | Evaluation of zotarolimus-eluting metal stent in animal ureters显示文摘 | Kallidonis P Kitrou P Karnabatidis D | 2011 | J Endourol2011，25，10： | 1 |
| 11 | Revisiting endovascular treatment in below-the-knee disease. Are drug-eluting stents the best option?显示文摘Patients with below-the-knee arterial disease are primarily individuals suffering from critical limb ischemia(CLI), while a large percentage of these patients are also suffering from diabetes or chronic renal failure or both. Available data from randomized controlled trials and their meta-analysis demonstrated that the use of infrapopliteal drug-eluting stents(DES), in short-to medium-length lesions, obtains significantly better results compared to plain balloon angioplasty and bare metal stenting with regards to vascular restenosis, target lesion revascularization, wound healing and amputations. Nonetheless, the use of this technology in every-day clinical practice remains limited mainly due to concerns regarding the deployment of a permanent metallic scaffold and the possibility of valid future therapeutic perspectives. However, in the majority of the cases, these concerns are not scientifically justified. Large-scale, multicenter randomized controlled trials, investigating a significantly larger number of patients than those already published, would provide more solid evidence and consolidate the use of infrapopliteal DES in CLI patients. Moreover, there is still little evidence on whether this technology can be as effective for longer below-the-knee lesions, where a considerable number of DES is required. The development and investigation of new, longer balloon-expanding or perhaps selfexpanding DES could be the answer to this problem. | Stavros Spiliopoulos Panagiotis M Kitrou Elias N Brountzos | 2018 | World Journal of Cardiology2018，10，11： | 1 |
| 12 | Evaluation of zotaroli- mus-eluting metal stent in animal ureters 显示文摘 | Kallidonis P Kitrou P Karnabatidis D | 2011 | J Endourol2011，25，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员